Groundbreaking iPSC Trial: First Patient Dosed with Novel cartilage Cell Therapy SEOUL — In a landmark achievement, YiPSCELL has announced the first-in-human administration of its iPSC-derived cartilage cell therapy, ‘MIUChon,’ …
Tag: